Sustained transdermal drug delivery depends on controlling how fast a drug leaves the patch and crosses the skin. Central formulation drivers include drug physicochemical properties, polymer matrix or membrane design, and the adhesive and excipient system that mediate contact with the stratum corneum. Foundational work by Robert Langer, Massachusetts Institute of Technology, and Nicholas A. Peppas, University of Texas at Austin, has clarified how diffusion, partitioning, and polymer relaxation govern release kinetics for polymer-based systems.
Formulation components
Drug factors such as molecular weight, lipophilicity, and solubility determine diffusivity within the matrix and partitioning into skin; small, moderately lipophilic molecules generally permeate more readily. The choice of polymer matrix or rate-controlling membrane sets the physical pathway: amorphous, low–glass transition temperature polymers permit faster diffusion, while crystalline or highly crosslinked networks slow release. Drug loading and the physical state of the drug—dissolved versus crystalline—affect the thermodynamic activity that drives flux. Use of permeation enhancers and solvents increases skin uptake but can raise irritation risk. Michael R. Prausnitz, Georgia Institute of Technology, has emphasized interactions between enhancers and skin structure in determining safe, reproducible enhancement.
Skin, environment, and application factors
The skin barrier is not constant. Stratum corneum thickness, hydration, and local blood flow alter uptake; application site and interindividual variation create clinically relevant variability. Temperature and humidity modulate diffusion and adhesive performance, so tropical climates can accelerate release and increase systemic exposure, while cold conditions may reduce efficacy. Cultural and territorial factors influence patch acceptance, wear location, and adherence to instructions, affecting real-world performance.
Consequences for safety and design
Poorly controlled formulation variables can cause dose dumping, subtherapeutic levels, or contact dermatitis. Regulatory and manufacturing attention must ensure consistent polymer properties, adhesive uniformity, and stability across storage conditions. Designing for target populations requires balancing sustained delivery with minimization of local irritation and environmental impact from disposable materials. Emphasizing reproducible polymer science, careful excipient selection, and attention to patient and environmental context yields safer, more effective transdermal systems.